These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19951245)

  • 1. Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users.
    Coupland H; Day C; Levy MT; Maher L
    Health Promot J Austr; 2009 Dec; 20(3):234-40. PubMed ID: 19951245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
    Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
    Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne.
    Maher L; Sargent P; Higgs P; Crofts N; Kelsall J; Le TT
    Aust N Z J Public Health; 2001; 25(1):50-4. PubMed ID: 11297303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.
    Souliotis K; Agapidaki E; Papageorgiou M; Voudouri N; Contiades X
    Int J Equity Health; 2017 Jun; 16(1):101. PubMed ID: 28615023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A; Treloar C; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).
    Kapadia F; Latka MH; Hagan H; Golub ET; Campbell JV; Coady MH; Garfein RS; Thomas DL; Bonner S; Thiel T; Strathdee SA
    J Urban Health; 2007 Jan; 84(1):99-115. PubMed ID: 17200799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.
    Fortier E; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Bruneau J; Grebely J;
    Int J Drug Policy; 2015 Nov; 26(11):1094-102. PubMed ID: 26145482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users.
    Brown K; Crofts N
    Aust N Z J Public Health; 1998; 22(3 Suppl):384-8. PubMed ID: 9629827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High hepatitis C incidence in new injecting drug users: a policy failure?
    Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
    Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up studies of treatment for hepatitis C virus infection among injection drug users.
    Dalgard O
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S336-8. PubMed ID: 15768344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada.
    Myles A; Mugford GJ; Zhao J; Krahn M; Wang PP
    Can J Gastroenterol; 2011 Mar; 25(3):135-9. PubMed ID: 21499577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.